Work

Utilization of Autologous HCT in Multiple Myeloma: A Novel Linkage of CIBMTR, Cancer Registry and Hospitalization Data in California

Year: 2022

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood-2022-159776

Authors: Naseem S Esteghamat, Ann M Brunson, Ted Wun, Aaron S Rosenberg, Julianne J.P. Cooley, Sara J. Schonfeld, Christa L. Meyer, Bryan Valcarcel, Renata Abrahao, Jeffery Auletta, Lindsay M. Morton, Lori Muffly, Theresa H.M. Keegan

Institutions: University of California Davis Medical Center, University of California, Davis, UC Davis Comprehensive Cancer Center, National Institutes of Health, Division of Cancer Epidemiology and Genetics, National Marrow Donor Program, Nationwide Children's Hospital, Stanford Medicine, Stanford University

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

OpenAlex ID: W4310112220

FWCI:

Cites:

Cited by:

Related to: 10